Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aritra Gangopadhyay

Bristol-Myers Squibb's Quarterly Earnings Preview: What You Need to Know

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. With a market cap of $120.8 billion, the company offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. BMY is expected to release its Q3 2026 earnings before the market opens on Thursday, October 29.

Ahead of this event, analysts anticipate the company will generate earnings of $1.48 per share, representing a decrease of 9.2% from $1.63 per share reported in the same quarter last year. The company has surpassed the Street’s bottom-line estimates in each of the past four quarters, which is impressive.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.